DTP-HepB-Hib liquid pentavalent vaccine (Biovac Institute)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameDTP-HepB-Hib liquid pentavalent vaccine (Biovac Institute)
Drug Alias NameN/A
ClassificationVaccines
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis BTetanusDiphtheria +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Africa
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioVac SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioVac SA
Active IndicationsN/A
Inactive IndicationsHepatitis BTetanusDiphtheria +[5] 

Other Information

ATC CodeN/A
Related LinksN/A